Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Doses”

40,367 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40,367 results

Testing effectiveness (Phase 2)Study completedNCT01144624
What this trial is testing

Assess Safety,and Tolerability of 2 Doses of AZD9773 (CytoFab™) in Japanese With Severe Sepsis/Septic Shock

Who this might be right for
Severe SepsisSeptic Shock
AstraZeneca 20
Testing effectiveness (Phase 2)Study completedNCT01376323
What this trial is testing

GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 92
Testing effectiveness (Phase 2)Study completedNCT07102459
What this trial is testing

An Efficacy and Safety Study of LTG-001 Following Abdominoplasty

Who this might be right for
Acute PainPostoperative Pain Control
Latigo Biotherapeutics 343
Early research (Phase 1)Ended earlyNCT03336580
What this trial is testing

PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis

Who this might be right for
Amyloidogenic Transthyretin (ATTR) Amyloidosis
Prothena Biosciences Limited 21
Early research (Phase 1)UnknownNCT02500680
What this trial is testing

The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)

Who this might be right for
Influenza, Human
Nova Immunotherapeutics Limited 102
Early research (Phase 1)Study completedNCT01987362
What this trial is testing

A Two Part Study of RO6870810. Dose-Escalation Study in Participants With Advanced Solid Tumors and Expansion Study in Participants With Selected Malignancies

Who this might be right for
Solid Tumors, Advanced Solid Tumors
Hoffmann-La Roche 52
Large-scale testing (Phase 3)Study completedNCT00386061
What this trial is testing

Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)

Who this might be right for
Obesity
Sanofi 1,507
Testing effectiveness (Phase 2)UnknownNCT05345873
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 300
Testing effectiveness (Phase 2)Study completedNCT04378569
What this trial is testing

Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema

Who this might be right for
Chronic Hand Eczema
Arcutis Biotherapeutics, Inc. 230
Not applicableStudy completedNCT00460954
What this trial is testing

A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects

Who this might be right for
Parkinson's Disease
Bristol-Myers Squibb 20
Not applicableActive Not RecruitingNCT06526156
What this trial is testing

Hypobaric L5-S1 Study

Who this might be right for
AnesthesiaAnesthesia, Local
University Health Network, Toronto 55
Not applicableStudy completedNCT03759951
What this trial is testing

Hybrid Exercise Training for Health, Performance and Well-Being (DoIT II)

Who this might be right for
High-Intensity Interval TrainingBody CompositionPerformance+1 more
University of Thessaly 120
Early research (Phase 1)Study completedNCT03719053
What this trial is testing

Single Dose Truvada Study

Who this might be right for
Medication AdherenceHIV Prevention
Johns Hopkins University 44
Testing effectiveness (Phase 2)Looking for participantsNCT07010237
What this trial is testing

Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia

Who this might be right for
Sever Aplastic AnaemiaElderly (People Aged 65 or More)Immunosuppressive Treatment
Institute of Hematology & Blood Diseases Hospital, China 65
Post-approval studies (Phase 4)Study completedNCT03723837
What this trial is testing

Persistence of IPV Immunity

Who this might be right for
Poliomyelitis
Tribhuvan University Teaching Hospital, Institute Of Medicine. 502
Testing effectiveness (Phase 2)Study completedNCT00528437
What this trial is testing

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

Who this might be right for
Brain Tumors
NYU Langone Health 46
Testing effectiveness (Phase 2)Study completedNCT00464737
What this trial is testing

The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.

Who this might be right for
Fibromyalgia Syndrome
UCB Pharma 230
Testing effectiveness (Phase 2)Study completedNCT01299480
What this trial is testing

A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years

Who this might be right for
Meningococcal Vaccine
Pfizer 1,714
Early research (Phase 1)Ended earlyNCT00651079
What this trial is testing

GSK1247303 First Time in Human Study

Who this might be right for
Healthy Subjects
GlaxoSmithKline 58
Early research (Phase 1)Study completedNCT04448561
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants

Who this might be right for
Opioid Use Disorder
Astellas Pharma Global Development, Inc. 24
Load More Results